Dyslipidemia. Hyperlipidaemia, unspecified
Conditions
Interventions
Intervention 1: Intervantion group: 5 geram sachet, three times a day during one month. Intervention 2: Control group: 5 gram sachet, three times a day during one month.
Treatment - Drugs
Placebo
Intervantion group: 5 geram sachet, three times a day during one month
Control group: 5 gram sachet, three times a day during one month
Sponsors
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1)adolescents between 12 to 18 years old that have at least one of these criteria: a: triglyceride more than 90 percentile b: total cholesterol more than 90 percentile c: LDL more than 90 percentile d:HDL less than 10 percentile 2) Not using tobacco 3) No history of alcohol consumption or drug abuse 4) No history of metabolic diseases like diabetes, thyroid gland dysfunction, nephrotic syndrome, chronic pancreatitis, liver and gall bladder diseases that affects lipid profiles 5) Not using drugs which affect lipid profiles like statins and hormonal pills like estrogens, progestrones and oral contraceptives. Exclusion criteria: 1) Lack of patient’s compliance with drug regimens at least for one week. 2) Pregnancy and lactation 3) Drug sensitivity 4) Suffering from any diseases which interact with lipid profiles 5) Intake of any kind of drugs or other compounds lowering lipid profile like corticosteroids, androgens, estrogenes, progestines, thiazides, beta blockers and thyroid hormones
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triglyceride. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;Total cholesterol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;LDL. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;HDL. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactIman Khayam
Isfahan University of Medical Sciences
Outcome results
None listed